Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Genmab revises financial guidance
Genmab, 08/18/09
Genmab A/S announced it is revising its 2009 financial guidance. We now expect our 2009 revenue to be approximately DKK 750 million compared to the previous estimate of DKK 1.2 billion. The reduction in revenue is primarily due to the exclusion of a milestone payment under the Arzerra collaboration with GlaxoSmithKline.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
IMS Predicts 4% to 6% Global Pharma Market Growth Next Year
U.S. Pharmacist, 12/02/09
Article Search
Sponsor